Alliance with AstraZeneca is CAT&#39;s whiskers for biotech firm
13123
UK biotechnology company Cambridge Antibody Technology has announced a five-year alliance with pharmaceutical giant AstraZeneca. CAT said AstraZeneca will make an upfront equity investment in CAT worth Â£75
683607
AtheroGenics announces the path forward for its lead drug.
296490
The small pharmaceutical firm signs another big deal.
121380
THE future of AstraZenecaâs blood-thinning medicine, Exanta, was thrown into fresh doubt last night after Franceâs leading drugs regulator confirmed that it was reviewing the medicineâs approval status.
729447
U.S. antitrust authorities on Wednesday approved AstraZeneca Plc's  plan to buy biotechnology company MedImmune Inc.  for more than $15 billion.
738382
The drug maker is poised to speed past its rivals.
291200
AstraZeneca said yesterday that it completed its $15.6 billion acquisition of MedImmune, capping the Gaithersburg firm's rise from a small start-up 19 years ago to one of the world's largest biotech companies.
351992
In the latest endorsement of a science technique discovered at the University of Massachusetts, the international drug giant Roche signed a $331 million deal with Alnylam Pharmaceuticals Inc. of Cambridge for the rights to develop drugs using RNA interference.
665690
The developing biopharmaceutical company announces a share offering.
627268
By Sharon Smyth  Merck, the German pharmaceutical company that failed to buy a rival, Schering, this year, agreed to buy the stake owned by the billionaire Ernesto Bertarelli in Serono to obtain control of the largest biotechnology company in Europe.
727152
New developments are brewing at the pharmaceutical.
471781
The company is ready to handle competition from generics.
366283
Roche and the US-based biopharmaceutical company Alnylam Pharmaceuticals, Inc.  on Monday unveiled a $1 billion alliance giving Roche rights to Alnylam's technology for developing so-called RNA interference therapies.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.
285697
Looking at drug R&D is the best way to begin assessing biotech companies.
321553
Blockbuster products help the biotech firm continue its stellar performance.
253298
The drug company pushes on after the Enhance trials.